Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples